Penumbra ($PEN), one of the top devicemaker IPOs last year, unveiled its latest thrombectomy product to the U.S. market. Dubbed the ACE 68 Reperfusion Catheter, the ...

February 28, 2008 (New Orleans, Louisiana) -- Results of a prospective, single-cohort, phase 2 study show safety and effectiveness for recanalization of the Penumbra System aspiration catheter in ...

Publicly traded global medical device company Penumbra expanded its portfolio to include virtual reality offerings through its REAL Immersive System in 2019. The system is designed to help clinicians ...

Californian device company Penumbra has announced one-year data from a trial that found using the Indigo Aspiration System to carry out a mechanical thrombectomy saw an 88.5% success rate at salvaging ...

The company forecasts fiscal year 2025 sales of $1.34 billion-$1.36 billion versus a consensus of $1.36 billion. Penumbra projects the U.S. thrombectomy franchise will grow 19% to 20% year over year, ...

Penumbra hopes to reinvigorate a medical device IPO market that's been taking time off since late June. It seems to stand a good chance to do so--with a stellar major shareholder, a pair of bulge ...

Penumbra, which markets surgical access devices for neuro and peripheral vascular conditions and diseases, announced terms for its IPO on Tuesday. The Alameda, CA-based company plans to raise $101 ...

Shares of Penumbra slid nearly 9% on Tuesday after short-seller Quintessential Capital Management released a critical report on the California-based medical devices maker. The stock was halted shortly ...

Let’s dig into the relative performance of Penumbra (NYSE:PEN) and its peers as we unravel the now-completed Q1 medical devices & supplies - cardiology, neurology, vascular earnings season. The ...

SILVER SPRING, MD — The Penumbra 3D Revascularization device has been recalled because of the potential for the delivery wire to break or separate during use and leave fractured pieces inside a ...

ALAMEDA — Penumbra has leased a still-unbuilt office building in Alameda, setting the stage for a major expansion by the medical devices maker that has experienced rising sales and profits. The health ...